EGFR and diabetic kidney disease: Increased N-glycan branching, corresponding to higher CA3, has also been shown to regulate the epidermal growth factor receptor and transforming growth factor-β pathways that are implicated in diabetic kidney disease.39 40 However, in our full model the associations of CA2 and CA3 were no longer significant.